{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:05:12Z","timestamp":1761609912782},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,1,20]],"date-time":"2016-01-20T00:00:00Z","timestamp":1453248000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s10067-016-3175-3","type":"journal-article","created":{"date-parts":[[2016,1,20]],"date-time":"2016-01-20T03:47:01Z","timestamp":1453261621000},"page":"649-655","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Polyarthritis in primary Sj\u00f6gren\u2019s syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up"],"prefix":"10.1007","volume":"35","author":[{"given":"E. J.","family":"ter Borg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. C.","family":"Kelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,20]]},"reference":[{"key":"3175_CR1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00002281-200309000-00007","volume":"15","author":"A Hansen","year":"2003","unstructured":"Hansen A, Lipsky PE, D\u00f6rner T (2003) New concepts in the pathogenesis of Sj\u00f6gren syndrome: many questions, fewer answers. Curr Opin Rheumatol 15:563\u2013570","journal-title":"Curr Opin Rheumatol"},{"key":"3175_CR2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2002) Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554\u2013558","journal-title":"Ann Rheum Dis"},{"key":"3175_CR3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.semarthrit.2010.07.006","volume":"40","author":"EJ Borg ter","year":"2011","unstructured":"ter Borg EJ, Risselada AP, Kelder JC (2011) Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sj\u00f6gren\u2019s syndrome: a retrospective analysis of 65 patients in the Netherlands. Semin Arthritis Rheum 40:547\u2013551","journal-title":"Semin Arthritis Rheum"},{"key":"3175_CR4","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/rheumatology\/keq047","volume":"49","author":"A-L Fauchais","year":"2010","unstructured":"Fauchais A-L, Quattara B, Gondran G, Lalloue F, Petit D, Lambert M et al (2010) Articular manifestations in primary Sj\u00f6gren\u2019s syndrome: clinical significance and prognosis of 188 patients. Rheumatology 49:1164\u20131172","journal-title":"Rheumatology"},{"issue":"3","key":"3175_CR5","first-page":"349","volume":"32","author":"EJ Borg ter","year":"2014","unstructured":"ter Borg EJ, Kelder JC (2014) Lower prevalence of extra-glandular manifestations and anti-SSB antibodies in patients with primary Sj\u00f6gren\u2019s syndrome and widespread pain: evidence for a relatively benign subset. Clin Exp Rheumatol 32(3):349\u2013353","journal-title":"Clin Exp Rheumatol"},{"key":"3175_CR6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/ard.2003.019794","volume":"64","author":"J-E Gottenberg","year":"2005","unstructured":"Gottenberg J-E, Mignot S, Nicaise-Rolland P, Cohen-Solal J, Autocoutourier F, Goetz J et al (2005) Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis 64:114\u2013117","journal-title":"Ann Rheum Dis"},{"key":"3175_CR7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","volume":"87","author":"M Ramos-Casals","year":"2008","unstructured":"Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, Pino-Montes J et al (2008) Primary Sj\u00f6gren syndrome in Spain. Clinical and immunological expression in 1010 patients. Medicine 87:210\u2013219","journal-title":"Medicine"},{"key":"3175_CR8","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/rheumatology\/ket427","volume":"53","author":"C Baldini","year":"2014","unstructured":"Baldini C, Pepe P, Quartuccion L, Priori R, Bartolini E, Aluno A et al (2014) Primary Sj\u00f6gren\u2019s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology 53:839\u2013844","journal-title":"Rheumatology"},{"key":"3175_CR9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/ard.60.5.467","volume":"60","author":"M Pertovaara","year":"2001","unstructured":"Pertovaara M, Pukkala E, Laippala P, Miettinen P, Pasternack A (2001) A longitudinal cohort study of Finnish patients with primary Sj\u00f6gren\u2019s syndrome: clinical, immunological, and epidemiological aspects. Ann Rheum Dis 60:467\u2013472","journal-title":"Ann Rheum Dis"},{"key":"3175_CR10","first-page":"485","volume":"10","author":"A Castro-Poltronieri","year":"1983","unstructured":"Castro-Poltronieri A, Alarcon-Segovia D (1983) Articular manifestations of primary Sj\u00f6gren\u2019s syndrome. J Rheumatol 10:485\u2013488","journal-title":"J Rheumatol"},{"key":"3175_CR11","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/ard.2004.029066","volume":"64","author":"MN Lazarus","year":"2005","unstructured":"Lazarus MN, Isenberg DA (2005) Development of additional autoimmune diseases in a population with primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis 64:1062\u20131064","journal-title":"Ann Rheum Dis"},{"key":"3175_CR12","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.3899\/jrheum.080234","volume":"36","author":"K Mohammed","year":"2009","unstructured":"Mohammed K, Pope J, le Riche N, Brintnell W, Cairns E, Coles R et al (2009) Association of severe inflammatory polyarthritis in primary Sj\u00f6gren\u2019s syndrome: clinical, serological and HLA analysis. J Rheumatol 36:1937\u20131942","journal-title":"J Rheumatol"},{"key":"3175_CR13","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/RHU.0b013e31826d2abb","volume":"18","author":"O Khan","year":"2012","unstructured":"Khan O, Carsons S (2012) Occurrence of rheumatoid arthritis requiring oral and\/or biological disease-modifying anti-rheumatic drug therapy following a diagnosis of primary Sj\u00f6gren\u2019s syndrome. J Clin Rheumatol 18:356\u2013358","journal-title":"J Clin Rheumatol"},{"key":"3175_CR14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3899\/jrheum.080193","volume":"36","author":"N Iwamoto","year":"2009","unstructured":"Iwamoto N, Kawakami A, Tamai M, Fujikawa K, Arima AT et al (2009) Determination of the subset of Sj\u00f6gren\u2019s syndrome with articular manifestations by anti-cyclic citrullinated peptide antibodies. J Rheumatol 36:113\u2013115","journal-title":"J Rheumatol"},{"key":"3175_CR15","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1093\/rheumatology\/kev200","volume":"54","author":"M Ramos-Casals","year":"2015","unstructured":"Ramos-Casals M, Brito-Zeron P, Seror R, Bootsma H, Bowman SJ, Dorner et al (2015) Characterisation of systemic disease in primary Sj\u00f6gren\u2019s syndrome: EULAR Task Force recommendations for articular, cutaneous and renal involvements. Rheumatology 54:2230\u20132238","journal-title":"Rheumatology"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3175-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-016-3175-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3175-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T21:02:40Z","timestamp":1567544560000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-016-3175-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,20]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["3175"],"URL":"https:\/\/doi.org\/10.1007\/s10067-016-3175-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,20]]}}}